- You are viewing a Navigating Care library resource.
- Back to Library
Treatment of Ductal Carcinoma In Situ (DCIS)
For information about the treatments listed below, see the Treatment Option Overview section.
Treatment of ductal carcinoma in situ may include:
- Breast-conserving surgery and radiation therapy, with or without tamoxifen.
- Total mastectomy with or without tamoxifen. Radiation therapy may also be given.
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
This information is not intended to replace the advice of a doctor.
Navigating Care disclaims any liability for the decisions you make based on this information.
This information was sourced and adapted from Adapted from the National Cancer Institute's
Physician Data Query (PDQ®) Cancer Information Summaries on
www.cancer.gov.
This information updated
November 1, 2024.
Learn more:
- General Information About Breast Cancer
- Stages of Breast Cancer
- Inflammatory Breast Cancer
- Types of Treatment for Breast Cancer
- Treatment of Early, Localized, or Operable Breast Cancer
- Treatment of Locally Advanced or Inflammatory Breast Cancer
- Treatment of Locoregional Recurrent Breast Cancer
- Treatment of Metastatic Breast Cancer
- Treatment of Ductal Carcinoma In Situ (DCIS)
- To Learn More About Breast Cancer
Related Articles
- General Information About Breast Cancer
- Stages of Breast Cancer
- Inflammatory Breast Cancer
- Types of Treatment for Breast Cancer
- Treatment of Early, Localized, or Operable Breast Cancer
- Treatment of Locally Advanced or Inflammatory Breast Cancer
- Treatment of Locoregional Recurrent Breast Cancer
- Treatment of Metastatic Breast Cancer
- Treatment of Ductal Carcinoma In Situ (DCIS)
- To Learn More About Breast Cancer
More Resources
See Expert Resources
The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the
the National Cancer Institute and other experts.
